Journal of Natural Products
Article
(+)-ESIMS m/z 481 [M + Na]+; (+)-HRESIMS m/z 481.3292 [M +
Na]+ (calcd for C29H46O4Na, 481.3288).
X-ray Crystallography of Compound 1. C29H46O4, M = 458.68,
monoclinic, P21, a = 14.374(6) Å, b = 7.464(6) Å, c = 15.053(7) Å, β =
116.02(1)°, V = 1451.3(2) Å3, Z = 2, Dcalcd = 1.183 g·cm−3, 4310
reflections independent, 3717 reflections observed (|F|2 ≥ 2σ|F|2), R1 =
0.0489, wR2 = 0.1312, S = 1.060.
The data were collected on a Rigaku MicroMax 002+ diffractometer
with Cu Kα radiation using the ω and κ scan technique to a maximum
2θ value of 144.56°. The crystal structures were solved by direct
methods using SHELXS-97, and all non-hydrogen atoms were refined
anisotropically using the least-squares method. All hydrogen atoms
were positioned by geometrical calculations and a difference Fourier
overlapping calculation. The absolute configuration was determined on
the basis of the Flack parameter of 0.0(3). Crystallographic data for the
structure of 1 have been deposited with the Cambridge Crystallo-
graphic Data Centre as supplementary publication CCDC 842894.
Copies of these data can be obtained free of charge at www.ccdc.cam.
Data Centre, 12 Union Road, Cambridge CB21EZ, UK; fax: (+44)
549 [M + Na]+; (+)-HRESIMS m/z 527.4484 [M + H]+ (calcd for
C35H59O3, 527.4459).
(+)-(20S)-20-O-Lauroylpregn-4-en-3-one (8): colorless gum;
[α]20 +38.2 (c 0.03, CHCl3); UV (MeOH) λmax (log ε) 204
D
(2.28), 240 (1.67) nm; ECD (MeOH) 233 (Δε +5.77), 323 (Δε
−1.14) nm; 1H NMR (CDCl3, 500 MHz) data, see Table 3; 13C NMR
(CDCl3, 125 MHz) data, see Table 3; (+)-ESIMS m/z 499 [M + H]+,
521 [M + Na]+; (+)-HRESIMS m/z 499.4164 [M + H]+ (calcd for
C33H55O3, 499.4146).
(+)-(20S)-20-O-Caprinoylpregn-4-en-3-one (9): colorless gum;
[α]20 +38.6 (c 0.06, CHCl3); UV (MeOH) λmax (log ε) 210
D
(2.57), 240 (1.64) nm; ECD (MeOH) 232 (Δε +5.24), 325 (Δε
−1.07) nm; 1H NMR (CDCl3, 500 MHz) data, see Table 3; 13C NMR
(CDCl3, 125 MHz) data, see Table 3; (+)-ESIMS m/z 471 [M + H]+,
493 [M + Na]+; (+)-HRESIMS m/z 471.3903 [M + H]+ (calcd for
C31H51O3, 471.3833).
(+)-(20S)-20-O-Capryloylpregn-4-en-3-one (10): colorless gum;
[α]20 +38.2 (c 0.06, CHCl3); UV (MeOH) λmax (log ε) 210 (2.61),
D
240 (1.66) nm; ECD (MeOH) 235 (Δε +5.37), 323 (Δε −1.09) nm;
1H NMR (CDCl3, 500 MHz) data, see Table 3; 13C NMR (CDCl3,
125 MHz) data, see Table 3; (+)-ESIMS m/z 443 [M + H]+, 465 [M
+ Na]+; (+)-HRESIMS m/z 443.3564 [M + H]+ (calcd for C29H47O3,
443.3520).
Hydrolysis of 6−10. Compound 6 (7.0 mg) was stirred with KOH
(10 mg) in methanol (3 mL) for 2 h. The reaction solution was
partitioned between H2O (25 mL) and CHCl3 (25 mL). The CHCl3
phase was evaporated under reduced pressure to give a residue that
(+)-(3S,7S,8S,13R,14S,17R,18R,19S,20S,21S)-25-Norfern-5(10),9-
(11)-diene-3,7,19,20,28-pentaol (2): white, amorphous powder;
[α]20 +59.4 (c 0.1, MeOH); UV (MeOH) λmax (log ε) 244 (1.49)
D
nm; ECD (MeOH) 245 (Δε +1.94) nm; IR νmax 3397, 2924, 2855,
1
1655, 1595, 1464, 1378, 1279, 1211, 1178. 1129, 1060, 973 cm−1; H
NMR (acetone-d6, 600 MHz) data, see Table 1; 13C NMR (acetone-
d6, 125 MHz) data, see Table 2; (+)-ESIMS m/z 497 [M + Na]+;
(+)-HRESIMS m/z 497.3231 [M + Na]+ (calcd for C29H46O5Na,
497.3237).
was separated by PTLC using petroleum ether−EtOAc (5:1) to afford
1
betulin with [α]20 +18.5 (c 0.06, CHCl3); H NMR (CDCl3, 500
D
MHz) and (+)-ESIMS data were identical with reported data.8
Similarly, compounds 8−10 were hydrolyzed to afford (20S)-20-
hydroxypregn-4-en-3-one with [α]20D +99.5 (c 0.2, CHCl3); 1H NMR
(CDCl3, 500 MHz) data were identical with reported data.11
(+)-(3S,7S,8S,13R,14S,17R,18R,21S)-25-Norfern-5(10),9(11)-diene-
19-oxo-3,7,28-triol (3): white, amorphous powder; [α]20 +55.6 (c
D
0.08, MeOH); UV (MeOH) λmax (log ε) 245 (1.52) nm; ECD
(MeOH) 241 (Δε +3.38), 286 (Δε −2.19) nm; IR νmax 3441, 2934,
2890, 1728, 1631, 1469, 1443, 1384, 1375, 1267, 1228, 1188, 1102,
1063, 1032, 999, 967 cm−1; 1H NMR (acetone-d6, 600 MHz) data, see
Table 1; 13C NMR (acetone-d6, 125 MHz) data, see Table 2;
(+)-ESIMS m/z 457 [M + H]+; (+)-HRESIMS m/z 457.3302 [M +
H]+ (calcd for C29H45O4, 457.3312), 479.3118 [M + Na]+ (calcd for
C29H44O4Na, 479.3132).
ASSOCIATED CONTENT
* Supporting Information
■
S
Copies of IR, MS, and 1D and/or 2D NMR for compounds 1−
10 and ECD spectra for 1−5 and 7−10. This can be accessed
(+)-(3S,4R,7S,8S,13R,14S,17R,18R,19R,21S)-25-Norfern-5(10),9-
AUTHOR INFORMATION
Corresponding Author
*Tel: 86-10-83154789. Fax: 86-10-63017757. E-mail: shijg@
■
(11)-diene-3,7,19,23,28-pentaol (4): white, amorphous powder;
[α]20 +32.5 (c 0.3, MeOH); UV (MeOH) λmax (log ε) 202 (1.93),
D
241 (2.05) nm; ECD (MeOH) 235 (Δε +6.50) nm; IR νmax 3389,
2935, 1643, 1458, 1443, 1376, 1283, 1186, 1085, 1040, 968, 947, 887
1
cm−1; H NMR (acetone-d6, 600 MHz) data, see Table 1; 13C NMR
Notes
(acetone-d6, 125 MHz) data, see Table 2; (+)-HRESIMS m/z 497 [M
+ Na]+; (+)-HRESIMS m/z 497.3253 [M + Na]+ (calcd for
C29H46O5Na, 497.3237).
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
(+)-(3S,5S,7S,8S,13R,14S,17R,18R,19R,21S)-25-Norfern-1(10),9-
■
(11)-diene-3,7,19,28-tetraol (5): white, amorphous powder; [α]20
D
Financial support from the National Natural Sciences
Foundation of China (NNSFC; grant nos. 30825044 and
20932007), the Program for Changjiang Scholars and
Innovative Research Team in University (PCSIRT, grant no.
IRT1007), and the National Science and Technology Project of
China (no. 2011ZX09307-002-01) is acknowledged.
+28 (c 0.05, MeOH); UV (MeOH) λmax (log ε) 236 (1.48) nm; ECD
(MeOH) 236 (Δε +2.69) nm; IR νmax 3192, 2921, 2850, 1647, 1470,
1
1421, 1380, 1127, 1037 cm−1; H NMR (acetone-d6, 600 MHz) data,
see Table 1; 13C NMR (acetone-d6, 125 MHz) data, see Table 2;
(+)-ESIMS m/z 481 [M + Na]+; (+)-HRESIMS m/z 481.3300 [M +
Na]+ (calcd for C29H46O4Na, 481.3288).
3-O-Myristoylbetulin (6): white, amorphous powder; [α]20 +31.5
D
REFERENCES
(c 0.08, CHCl3); IR νmax 2926, 2854, 1731, 1466, 1375, 1248, 1178,
■
1
1035, 980, 881, 722 cm−1; H NMR (CDCl3, 500 MHz) data, see
(1) Jiangsu New Medical College. Dictionary of Traditional Chinese
Medicine; Shanghai Science and Technology Publishing House:
Shanghai, 1986; p 2514.
(2) Jia, H. H.; Wu, X. D. Zhong Yao Cai 1992, 15, 35−36.
(3) Xiong, L.; Zhu, C. G.; Li, Y. R.; Tian, Y.; Lin, S.; Yuan, S. P.; Hu,
J. F.; Hou, Q.; Chen, N. H.; Yang, Y. C.; Shi, J. G. J. Nat. Prod. 2011,
74, 1188−1200.
(4) Gawronski, J. K.; Walborsky, H. M. In Circular Dichroism
Principles and Applications; Nakanishi, K.; Berova, N.; Woody, R. W.,
Ed.; Wiley-VCH, Inc.: New York, 1994; Chapter 11, pp 301−330.
Table 1; 13C NMR (CDCl3, 125 MHz) data, see Table 2; EIMS m/z
652 [M]+•; HREIMS m/z 652.5783 [M]+• (calcd for C44H76O3
652.5794).
(+)-(20S)-20-O-Myristoylpregn-4-en-3-one (7): colorless gum;
[α]20 +38 (c 0.03, CHCl3); UV (MeOH) λmax (log ε) 211 (2.42),
D
240 (1.65) nm; ECD (MeOH) 235 (Δε +5.78), 322 (Δε −1.21) nm;
IR νmax 2927, 2854, 1730, 1669, 1459, 1379, 1175, 1076, 948, 866
1
cm−1; H NMR (CDCl3, 500 MHz) data, see Table 3; 13C NMR
(CDCl3, 125 MHz) data, see Table 3; (+)-ESIMS m/z 527 [M + H]+,
1165
dx.doi.org/10.1021/np300259s | J. Nat. Prod. 2012, 75, 1160−1166